Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eltrombopag in Refractory Diamond-Blackfan Anemia
NCT04269889Phase 2Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Dec 2020
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of eltrombopag in Diamond-Blackfan anemia (DBA), sponsored by National Heart, Lung, and Blood Institute. Started Dec 2020; status: completed.
02
Drugs
eltrombopag
03
Conditions
Diamond-Blackfan anemia (DBA)
Beyond the preview
Go deeper on NCT04269889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04269889.